Goldman Sachs upgraded Thoratec (NASDAQ: THOR) from Neutral to Buy, raises price target of $45.00.

Analyst, David H. Roman ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE